National Vision Holdings, Inc.
Investors that purchased the Company’s securities and have suffered a loss, please fill in transaction information below, or email to info@portnoylaw.com.
There is no cost or obligation associated with submitting your information. If you are a shareholder who suffered a loss, please submit your contact information and purchase information to participate in the putative class action.
We also encourage you to contact Lesley F. Portnoy of The Portnoy Law Firm, at 310.692.8883, to discuss your rights free of charge. You can also reach us through the firm’s website at www.portnoylaw.com, or by email at info@portnoylaw.com.
If you choose to take no action, you can remain an absent class member.
Joining the case through the Portnoy Law website enables investors to learn about their legal claims and take an active role in recovering their losses.
The Portnoy Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
CONTACT:
Portnoy Law Firm
Lesley F. Portnoy, Esq.,
www.portnoylaw.com
Office: 310.692.8883
1800 Century Park East, Suite 600
Los Angeles, CA 90067
info@portnoylaw.com
National Vision Holdings Inc. is facing a lawsuit for allegedly misrepresenting its financial and operational prospects during the class period. The defendants repeatedly raised the Company’s guidance, claiming that National Vision was navigating the pandemic and outperforming the industry. However, these assurances were false and misleading, as the Company was struggling to retain and recruit critical healthcare staff sufficient to keep up with surging customer demand. The Company implemented a significant wage investment, which impaired the earnings, and concealed the investment’s scope. The efforts ultimately failed to address the Company’s retention and recruitment crisis, which resulted in a pronounced optometrist shortage by the first quarter of 2022, negatively impacting the Company’s financial and operational results. The stock price traded at artificially inflated prices until May 10, 2022, when the Company issued disappointing financial and operational results for the first quarter of 2022, causing the stock price to drop by almost 26%.
